Amplia Therapeutics

(ASX) ATX

Current Price$0.15

Market Cap$76.96M

Since IPO (2013)-92%

5 Year-47%

1 Year+206%

1 Month-36%

Amplia Therapeutics Financials at a Glance

Market Cap

$76.96M

Revenue (TTM)

$5.79M

Net Income (TTM)

$14.12M

EPS (TTM)

$-0.02

P/E Ratio

-7.46

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$0.15

Volume

399,313

Open

$0.15

Price

$0.15

Volume

399,313

Open

$0.15

Previous Close

$0.15

Daily Range

$0.14 - $0.15

52-Week Range

$0.05 - $0.42

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$0.15

Volume

399,313

Open

$0.15

Previous Close

$0.15

Daily Range

$0.14 - $0.15

52-Week Range

$0.05 - $0.42

ATX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplia Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Christopher J. Burns, PhD

Website

www.ampliatx.com

Headquarters

Melbourne, VIC 3000, AU

ATX Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-5%

Net Income Margin

-3%

Return on Equity

-28%

Return on Capital

-25%

Return on Assets

-18%

Earnings Yield

-13.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$76.96M

Shares Outstanding

513.07M

Volume

399.31K

Avg. Volume

4.20M

Financials (TTM)

Gross Profit

$3.57M

Operating Income

$6.52M

EBITDA

$6.78M

Operating Cash Flow

$6.89M

Capital Expenditure

$2.07K

Free Cash Flow

$6.89M

Cash & ST Invst.

$10.86M

Total Debt

$13.89K

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$36.30K

-101.5%

Gross Margin

0.00%

N/A

Market Cap

$76.96M

N/A

Market Cap/Employee

$76.96M

N/A

Employees

N/A

Net Income

$4.18M

-269.9%

EBITDA

$6.77M

-94.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$28.78M

+742.2%

Accounts Receivable

$6.40M

+78.0%

Inventory

$0.00

N/A

Long Term Debt

$297.58K

+441.2%

Short Term Debt

$83.84K

-96.2%

Return on Assets

-17.81%

N/A

Return on Invested Capital

-24.88%

N/A

Free Cash Flow

$7.67M

-116.6%

Operating Cash Flow

$7.65M

-115.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CYP.AXCynata Therapeutics Limited

CYP.AXCynata Therapeutics Limited$0.32+0.63%

CYC.AXCyclopharm Limited

CYC.AXCyclopharm Limited$0.72+0.00%

M7T.AXMach7 Technologies Limited

M7T.AXMach7 Technologies Limited$0.27+3.92%

PTX.AXPrescient Therapeutics Limited

PTX.AXPrescient Therapeutics Limited$0.05+5.88%

RAD.AXRadiopharm Theranostics Limited

RAD.AXRadiopharm Theranostics Limited$0.02+0.00%

PIQ.AXProteomics International Laboratories Limited

PIQ.AXProteomics International Laboratories Limited$0.25+6.38%

MX1.AXMicro-X Limited

MX1.AXMicro-X Limited$0.05+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About ATX

What is the current price of Amplia Therapeutics?

Amplia Therapeutics is trading at A$0.15 per share.

What is the 52-week range for Amplia Therapeutics?

Over the past 52 weeks, Amplia Therapeutics has traded between A$0.05 and A$0.43.

How much debt does Amplia Therapeutics have?

As of the most recent reporting period, Amplia Therapeutics reported total debt of $13,893.

How much cash does Amplia Therapeutics have on hand?

Amplia Therapeutics reported $10.86M in cash and cash equivalents in its most recent financial results.

What is Amplia Therapeutics’s dividend yield?

Amplia Therapeutics does not currently have a dividend yield.

Amplia Therapeutics

Amplia Therapeutics Financials at a Glance

ATX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amplia Therapeutics

ATX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATX

What is the current price of Amplia Therapeutics?

What is the 52-week range for Amplia Therapeutics?

How much debt does Amplia Therapeutics have?

How much cash does Amplia Therapeutics have on hand?

What is Amplia Therapeutics’s dividend yield?

Premium Investing Services